Results 261 to 270 of about 19,226,899 (298)

Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)

2021
Both chronic hepatitis B (CHB) and hepatitis D (CHD) are major causes of liver related morbidity and mortality. Treatment indications for CHB are based on level of viremia, inflammation and extent of fibrosis. Treatment may consist of finite pegylated interferon therapy or long-term treatment with nucleo(s)tide analogs.
Sonneveld, Milan J., van Meer, Suzanne
openaire   +2 more sources

Changing pattern of chronic hepatitis D in Southern Europe

Gastroenterology, 1999
The aim of this study was to assess changes in the clinical pattern of hepatitis D virus (HDV) infection in Italy, brought about by improved control of hepatitis B and D viruses, and to establish the natural history of chronic hepatitis D.Histological diagnosis and clinical features of 122 patients with HDV recruited from 1987 to 1996 in three Italian ...
ROSINA F, CONOSCITORE P, CUPPONE R, ROCCA G, GIULIANI A, COZZOLONGO R, NIRO G, SMEDILE, Antonina, SARACCO, Giorgio Maria, ANDRIULLI A, MANGHISI OG, RIZZETTO, Mario   +11 more
openaire   +3 more sources

Pathology of Acute and Chronic Hepatitis D

1989
Since the discovery of the delta antigen by Rizzetto et al.1 10 years ago, the pathology of delta hepatitis has been described in detail. In recent years, several studies recorded significant differences in the clinical course and pathologic findings of hepatitis delta virus (HDV) infection in South America as opposed to those in North America and ...
openaire   +1 more source

Bulevirtide for Chronic Hepatitis D. Reply.

The New England journal of medicine, 2023
Wedemeyer, Heiner, Lampertico, Pietro
openaire   +2 more sources

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

New England Journal of Medicine
In a phase 3 trial, bulevirtide monotherapy led to a virologic response in patients with chronic hepatitis D. Pegylated interferon (peginterferon) alfa-2a is recommended by guidelines as an off-label treatment for this disease. The role of combination therapy with bulevirtide and peginterferon alfa-2a, particularly with regard to finite treatment, is ...
Asselah, Tarik, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pântea, Victor, Lazar, Stefan, Placinta, Gheorghe, Gherlan, George S, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Da, Ben L, Chee, Grace, Lau, Audrey H, Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Zoulim, Fabien   +25 more
openaire   +3 more sources

Chronic Hepatitis B Virus and Hepatitis D Virus

Clinics in Liver Disease, 2023
Ann Robinson, Robert Wong, Robert G. Gish   +2 more
openaire   +1 more source

Demonstration of Hepatitis D Virus RNA in Patients with Chronic Hepatitis

Journal of Infectious Diseases, 1988
R, Rasshofer, M, Buti, R, Esteban, R, Jardi, M, Roggendorf   +4 more
openaire   +2 more sources

Chronic hepatitis D

Dokazatel'naya gastroenterologiya, 2015
openaire   +1 more source

The role of vitamin D in chronic hepatitis

Forum Zakażeń, 2015
Aleksandra Berkan-Kawińska, Anna Piekarska   +1 more
openaire   +1 more source

Chronic hepatitis delta with normal ALT and hepatitis D viremia

Journal of Hepatology, 2022
Sena Arici, Adriana Palom, Mesut Gumussoy, Ramazan Idilman, Genco Gencdal, Rafael Esteban, Mujdat Zeybel, Maria Buti, Cihan Yurdaydin   +8 more
openaire   +1 more source